KUMUDA R. PRADHAN, MD
LA CROSSE, WI
What does KUMUDA PRADHAN research?
Dr. Pradhan studies treatments for specific blood cancers, including acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). Her research emphasizes the use of targeted therapies, such as new drug combinations that can overcome resistance in cancer treatment. She is also keen on refining synthetic methods for producing complex organic compounds that are vital in medication manufacturing, allowing for faster and easier development of new drugs. This double focus on patient care and pharmaceutical innovation presents important advancements in oncology and medication synthesis.
Key findings
- In the EMBER-3 trial, 72% of patients on standard treatment reported issues at injection sites compared to those taking imlunestrant, highlighting improved quality of life for patients using the new oral medication.
- 70% of elderly patients with acute myeloid leukemia responded positively to a treatment combining decitabine and venetoclax, with an average survival time of approximately 11.3 months.
- The use of a new STAT3 degrader demonstrated improved survival rates in mice with venetoclax-resistant acute myeloid leukemia by effectively lowering harmful protein levels.
Frequently asked questions
- Does Dr. Pradhan study blood cancer?
- Yes, Dr. Pradhan focuses on treatments for acute myeloid leukemia and myelodysplastic syndromes.
- What new treatments has Dr. Pradhan researched?
- She has researched novel drug combinations like decitabine with venetoclax and new oral medications for breast cancer.
- Is Dr. Pradhan's work relevant to elderly cancer patients?
- Yes, her studies specifically aim to improve therapies for elderly patients with conditions like myelodysplastic syndromes and acute myeloid leukemia.
- How does Dr. Pradhan's research impact drug development?
- Her work on new synthetic methods allows for easier and faster production of drugs, which can lead to more effective treatments.
- What are the potential outcomes of Dr. Pradhan's research?
- Her research has the potential to improve survival rates and quality of life for cancer patients, as well as speed up the development of necessary medications.
Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.